David Buckler

David Buckler is the Executive Director of Research Program Management at Regeneron Pharmaceuticals, Inc., where they manage cross-functional and interdepartmental aspects of target discovery and validation. Prior to this role, they held various leadership positions at Regeneron and Dyax Corp, focusing on therapeutic antibody discovery, high-throughput screening, and strategic operations. David earned a Ph.D. in Chemistry from the Massachusetts Institute of Technology and completed a postdoctoral fellowship at Cornell University. Their extensive background includes expertise in bio-therapeutic assay development, proteomics, and synthetic chemistry.